DKA features [7]
Polyuria, polydipsia
Abdominal pain/ vomiting/ nausea
Hyperventilation/ Kusmal breathing
Tachycardia, hypotensive
Reducing GCS
Succussion/ gastric splash
Ketone breath
Features of severe DKA
GCS < 12
pH <7.2
O2 < 90%
Ketones > 7 ?
Investigations in DKA
Bloods
Ketones
ECG
Urine dip/ urinalysis
Imaging
- CXR if infective signs
Initial management of DKA
Analgesia for pain
IV fluid resus
Fixed-rated insulin
Oxygen if hypoxic
Further management of DKA
When glucose reaches 14mmol/L
Give K+
- Monitor at least 4 hourly
Transition to variable rate insulin
Precipitating factors for DKA [5]
Poor glycaemia control
Acute infection
Surgery
Stress
Trauma
Life-threatening complications of DKA [3]
Cerebral oedema
Hypokalaemia
Aspiration pnemonia
Addison’s disease
- Presentation
Low cortisol features
Low mineralocorticoid features
Hyperpigmented skin
Initial Investigations for addison’s disease
Standing and sitting BP
BMI
Bloods
9am salivary cortisol
- Low
Special investigations for addison’s disease
SynACTHen test
- Low cortisol production
Abdominal ultrasound
- rule out CAH
Risk factors for addison’s disease
Family Hx
Autoimmune endocrinological disease
Post infective
Addisonian crisis
- Features
Acute, abdominal pain
- Vomiting/ nausea
Lethargy
Altering consciousness
Examination and investigative findings for addisonian crisis
Hypotension
Hyponatraemia, hypoglycaemia
Hyperkalaemia
Management of addisonian crisis
Analgesia for pain
A-E
- IV fluid saline resuscitation
IV hydrocortisone
IV hydrocortisone in 5% glucose over 24 hours by IV infusion.
What enzyme is the most common deficient in congenital adrenal hyperplasia?
21-hydroxylase
Less common
- 11-beta hydroxylase
Presentation of CAH
Precocious puberty
Salt wasting
Hypoglycaemia
Severe
Complications of gigantism [5]
Hyperhidrosis
Recurrent headaches
Cardiomyopathy
Hypopituitarism
Thyroid cancer
_______ inhibits the release of growth hormone
Somatostatin
GH acts on the liver to release ______
IGF-1
What genetic conditions are associated with gigantism?
Multiple endocrinological neoplasia type 1
Neurofibromatosis
McCune Albright syndrome
Features of gigantism
Intracranial
MSK
Skin
Development
- Delayed puberty
Metabolic
Diagnostic tests for gigantism
Plasma IGF-1
Oral glucose tolerance test
- 75g glucose does not lower GH levels <1mcg/L
Imaging
- Pituitary MRI
Management of gigantism
Somatostatin analogues= octreotide IM
2nd line
- Carbogoline (dopamine agonist)
Surgery
- Transphenoidal hypophysectomy